These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 24380960)

  • 1. New approach to the neurobiological mechanisms of addiction.
    Fürst Z; Riba P; Al-Khrasani M
    Neuropsychopharmacol Hung; 2013 Dec; 15(4):189-205. PubMed ID: 24380960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A neuropeptide-centric view of psychostimulant addiction.
    Boutrel B
    Br J Pharmacol; 2008 May; 154(2):343-57. PubMed ID: 18414383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New horizons for therapeutics in drug and alcohol abuse.
    Jupp B; Lawrence AJ
    Pharmacol Ther; 2010 Jan; 125(1):138-68. PubMed ID: 19917308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoids, opioids and MDMA: neuropsychological interactions related to addiction.
    Robledo P
    Curr Drug Targets; 2010 Apr; 11(4):429-39. PubMed ID: 20017726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic pharmacotherapy for substance use disorder.
    Sartor GC
    Biochem Pharmacol; 2019 Oct; 168():269-274. PubMed ID: 31306644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similarities and Differences in Genetics.
    Zhang Y; Sun Y; Liang J; Lu L; Shi J
    Adv Exp Med Biol; 2017; 1010():59-71. PubMed ID: 29098668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rebalancing the Addicted Brain: Oxytocin Interference with the Neural Substrates of Addiction.
    Bowen MT; Neumann ID
    Trends Neurosci; 2017 Dec; 40(12):691-708. PubMed ID: 29128108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the Oxytocin System to Treat Addictive Disorders: Rationale and Progress to Date.
    Lee MR; Rohn MC; Tanda G; Leggio L
    CNS Drugs; 2016 Feb; 30(2):109-23. PubMed ID: 26932552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circadian clock genes: effects on dopamine, reward and addiction.
    Parekh PK; Ozburn AR; McClung CA
    Alcohol; 2015 Jun; 49(4):341-9. PubMed ID: 25641765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A genetic view of addiction].
    Ramoz N; Gorwood P
    Med Sci (Paris); 2015 Apr; 31(4):432-8. PubMed ID: 25958762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex differences in neural mechanisms mediating reward and addiction.
    Becker JB; Chartoff E
    Neuropsychopharmacology; 2019 Jan; 44(1):166-183. PubMed ID: 29946108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotrophic mechanisms in drug addiction.
    Bolaños CA; Nestler EJ
    Neuromolecular Med; 2004; 5(1):69-83. PubMed ID: 15001814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Epigenetics in Addiction: Clinical Overview and Recent Updates.
    Beayno A; El Hayek S; Noufi P; Tarabay Y; Shamseddeen W
    Methods Mol Biol; 2019; 2011():609-631. PubMed ID: 31273724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights on neurobiological mechanisms underlying alcohol addiction.
    Cui C; Noronha A; Morikawa H; Alvarez VA; Stuber GD; Szumlinski KK; Kash TL; Roberto M; Wilcox MV
    Neuropharmacology; 2013 Apr; 67():223-32. PubMed ID: 23159531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arresting the Development of Addiction: The Role of
    Porter-Stransky KA; Weinshenker D
    J Pharmacol Exp Ther; 2017 Jun; 361(3):341-348. PubMed ID: 28302862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroscience of alcoholism: molecular and cellular mechanisms.
    Moonat S; Starkman BG; Sakharkar A; Pandey SC
    Cell Mol Life Sci; 2010 Jan; 67(1):73-88. PubMed ID: 19756388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The epigenetic landscape of addiction.
    Maze I; Nestler EJ
    Ann N Y Acad Sci; 2011 Jan; 1216():99-113. PubMed ID: 21272014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel medications to treat addictive disorders.
    Montoya ID; Vocci F
    Curr Psychiatry Rep; 2008 Oct; 10(5):392-8. PubMed ID: 18803912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neurobiology of addictive disorders.
    Ross S; Peselow E
    Clin Neuropharmacol; 2009; 32(5):269-76. PubMed ID: 19834992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role for dopamine in the behavioral functions of the prefrontal corticostriatal system: implications for mental disorders and psychotropic drug action.
    Jentsch JD; Roth RH; Taylor JR
    Prog Brain Res; 2000; 126():433-53. PubMed ID: 11105661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.